Parvovirus B19 myocarditis in children: An observational study

Archives of Disease in Childhood

Volumn 101, Issue 2, 2016, Pages 177-180

  Vigneswaran, Trisha V ^a,b   Brown, Julianne R ^a,c   Breuer, Judith ^a,d   Burch, Michael ^a  

^a GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^b EVELINA LONDON CHILDREN S HOSPITAL   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; AMIODARONE; ANTICOAGULANT AGENT; CARVEDILOL; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOPAMINE; IMMUNOGLOBULIN; INOTROPIC AGENT; MILRINONE;

ADOLESCENT; ARTICLE; ARTIFICIAL VENTILATION; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONGESTIVE CARDIOMYOPATHY; DISEASE COURSE; EVENT FREE SURVIVAL; EXTRACORPOREAL OXYGENATION; FEMALE; GENE IDENTIFICATION; HEART ARREST; HEART DEATH; HEART FAILURE; HEART FUNCTION; HEART MUSCLE BIOPSY; HEART TRANSPLANTATION; HEART VENTRICLE TACHYCARDIA; HUMAN; HUMAN PARVOVIRUS B19; INFANT; MALE; MITRAL VALVE REGURGITATION; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PARVOVIRUS B19 MYOCARDITIS; PARVOVIRUS INFECTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PRODROMAL SYMPTOM; RETROSPECTIVE STUDY; ST SEGMENT ELEVATION; SURVIVAL; VIRUS GENOME; VIRUS MYOCARDITIS; CONVALESCENCE; HEART LEFT VENTRICLE FUNCTION; ISOLATION AND PURIFICATION; MYOCARDITIS; PARVOVIRIDAE INFECTIONS; PATHOPHYSIOLOGY; PHYSIOLOGY; PRESCHOOL CHILD; PROCEDURES; PROGNOSIS; TREATMENT OUTCOME; VIROLOGY;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE; MYOCARDITIS; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN; POLYMERASE CHAIN REACTION; PROGNOSIS; RECOVERY OF FUNCTION; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT;

EID: 84956787160     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/archdischild-2014-308080     Document Type: Article

References (32)

1. Amabile N, Fraisse A, Bouvenot J, et al. Outcome of acute fulminant myocarditis in children. Heart 2006;92:1269-73.
2. Munro K, Croxson MC, Thomas S, et al. Three cases of myocarditis in childhood associated with human parvovirus (B19 virus). Pediatr Cardiol 2003;24:473-5.
3. Murry CE, Jerome KR, Reichenbach DD. Fatal parvovirus myocarditis in a 5-year-old girl. Hum Pathol 2001;32:342-5.
4. Papadogiannakis N, Tolfvenstam T, Fischler B, et al. Active, fulminant, lethal myocarditis associated with parvovirus B19 infection in an infant. Clin Infect Dis 2002;35:1027-31.
5. Molina KM, Garcia X, Denfield SW, et al. Parvovirus B19 myocarditis causes significant morbidity and mortality in children. Pediatr Cardiol 2013;34:390-7.
6. Kühl U, Pauschinger M, Seeberg B, et al. Viral persistence in the myocardium is associated with progressive cardiac dysfunction. Circulation 2005;112:1965-70.
7. Nigro G, Bastianon V, Colloridi V, et al. Human parvovirus B19 infection in infancy associated with acute and chronic lymphocytic myocarditis and high cytokine levels: report of 3 cases and review. Clin Infect Dis 2000;31:65-9.
8. Bowles NE, Ni J, Kearney DL, et al. Detection of viruses in myocardial tissues by polymerase chain reaction. Evidence of adenovirus as a common cause of myocarditis in children and adults. J Am Coll Cardiol 2003;42:466-72.
9. Kühl U, Schultheiss HP. Myocarditis in children. Heart Fail Clin 2010;6:483-96, viii-ix.
10. Miranda JO, Costa L, Rodrigues E, et al. Paediatric dilated cardiomyopathy: clinical profile and outcome. The experience of a tertiary centre for paediatric cardiology. Cardiol Young 2015;25:333-7.
11. von Kaisenberg CS, Bender G, Scheewe J, et al. A case of fetal parvovirus B19 myocarditis, terminal cardiac heart failure, and perinatal heart transplantation. Fetal Diagn Ther 2001;16:427-32.
12. Respondek M, Bratosiewicz J, Pertynski T, et al. Parvovirus particles in a fetal-heart with myocarditis: ultrastructural and immunohistochemical study. Arch Immunol Ther Exp (Warsz) 1997;45:465-70.
13. Andrews RE, Fenton MJ, Ridout DA, et al. New-onset heart failure due to heart muscle disease in childhood: a prospective study in the United Kingdom and reland. Circulation 2008;117:79-84.
14. Knöll A, Louwen F, Kochanowski B, et al. Parvovirus B19 infection in pregnancy: quantitative viral DNA analysis using a kinetic fluorescence detection system (TaqMan PCR). J Med Virol 2002;67:259-66.
15. Baughman KL. Diagnosis of myocarditis: death of Dallas criteria. Circulation 2006;113:593-5.
16. Ross RD, Daniels SR, Schwartz DC, et al. Plasma norepinephrine levels in infants and children with congestive heart failure. Am J Cardiol 1987;59:911-14.
17. Alvarez JA, Orav EJ, Wilkinson JD, et al. Competing risks for death and cardiac transplantation in children with dilated cardiomyopathy: results from the pediatric cardiomyopathy registry. Circulation 2011;124:814-23.
18. Daubeney PE, Nugent AW, Chondros P, et al. Clinical features and outcomes of childhood dilated cardiomyopathy: results from a national population-based study. Circulation 2006;114:2671-8.
19. English RF, Janosky JE, Ettedgui JA, et al. Outcomes for children with acute myocarditis. Cardiol Young 2004;14:488-93.
20. Klingel K, Sauter M, Bock CT, et al. Molecular pathology of inflammatory cardiomyopathy. Med Microbiol Immunol 2004;193:101-7.
21. Foerster SR, Canter CE, Cinar A, et al. Ventricular remodeling and survival are more favorable for myocarditis than for idiopathic dilated cardiomyopathy in childhood: an outcomes study from the pediatric cardiomyopathy registry. Circ Heart Fail 2010;3:689-97.
22. Kuethe F, Lindner J, Matschke K et al. Prevalence of parvovirus B19 and human bocavirus DNA in the heart of patients with no evidence of dilated cardiomyopathy or myocarditis. Clin Infect Dis 2009;49:1660-6.
23. Bock CT, Klingel K, Kandolf R. Human parvovirus B19-associated myocarditis. N Engl J Med 2010;362:1248-9.
24. Schowengerdt KO, Ni J, Denfield SW, et al. Association of parvovirus B19 genome in children with myocarditis and cardiac allograft rejection: diagnosis using the polymerase chain reaction. Circulation 1997;96:3549-54.
25. Mahfoud F, Gärtner B, Kindermann M, et al. Virus serology in patients with suspected myocarditis: utility or futility? Eur Heart J 2011;32:897-903.
26. McCarthy RE III, Boehmer JP, Hruban RH, et al. Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis. N Engl J Med 2000;342:690-5.
27. Dennert R, Crijns HJ, Heymans S. Acute viral myocarditis. Eur Heart J 2008;29:2073-82.
28. O'Sullivan JJ, Roche SL, Crossland DS, et al. Recovery of heart function in children with acute severe heart failure. Transplantation 2008;85:975-9.
29. Jones CB, Cassidy JV, Kirk R, et al. Successful bridge to recovery with 120 days of mechanical support in an infant with myocarditis. J Heart Lung Transplant 2009;28:202-5.
30. Lee KJ, McCrindle BW, Bohn DJ, et al. Clinical outcomes of acute myocarditis in childhood. Heart 1999;82:226-33.
31. Ghelani SJ, Spaeder MC, Pastor W, et al. Demographics, trends, and outcomes in pediatric acute myocarditis in the United States, 2006 to 2011. Circ Cardiovasc Qual Outcomes 2012;5:622-7.
32. Freund MW, Kleinveld G, Krediet TG, et al. Prognosis for neonates with enterovirus myocarditis. Arch Dis Child Fetal Neonatal Ed 2010;95:F206-12.